Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide Oral Versus Placebo for Reduction of Hospital Length of Stay in Postpartum Women With Severe Preeclampsia
NCT07648251Phase 2Not yet recruiting
- Sponsor
- Universidad Nacional Autónoma de Honduras
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide in preeclampsia, sponsored by Universidad Nacional Autónoma de Honduras. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
furosemide
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT07648251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07648251.